Key Takeaways

• New Medicare drug price negotiations bring notable changes to prescription costs for PSHB and FEHB participants in 2026.
• Legislative updates and plan structures will influence out-of-pocket expenses—knowing the facts can aid in proactive healthcare planning.

Did you know new Medicare drug pricing rules may change how federal retirees manage prescriptions in 2026? Here’s what matters for PSHB and FEHB members. This guide will help you understand drug pricing developments, what’s driving them, and how your benefits may be affected.

What Are Medicare Negotiated Drug Prices?

Definition and basic overview

Medicare negotiated drug prices refer to the prices that the Centers for Medicare & Medicaid Services (CMS) has worked directly with pharmaceutical manufacturers to set for certain prescription medications. This process aims to make widely used and high-cost drugs more affordable for those with Medicare coverage. Instead of accepting a manufacturer’s list price, Medicare will have authority to secure lower costs on select drugs that meet specific criteria.

How price negotiation works

The negotiation process starts with CMS identifying eligible drugs—typically those with the highest total spending or those without generic alternatives. CMS then enters discussions with pharmaceutical companies to determine how much Medicare will pay for each selected medication. Once a final price is determined, it becomes the maximum Medicare will pay for that drug for all beneficiaries enrolled in Medicare, including those in integrated programs like PSHB.

How Do Medicare Drug Prices Influence PSHB?

PSHB plan structure and integration

The Postal Service Health Benefits (PSHB) Program, which began on January 1, 2025, is designed exclusively for Postal Service employees, retirees, and their dependents. PSHB plans integrate with Medicare, especially for annuitants aged 65 and older, meaning these plans work alongside your Medicare coverage. Drug coverage inside PSHB is now closely aligned with Medicare Part D, so any changes to Medicare drug prices directly influence the cost structures in PSHB plans.

Interaction with Medicare Part D

Medicare Part D is the prescription drug benefit program for Medicare beneficiaries. PSHB plans coordinate with Medicare Part D—if you’re eligible, your prescription drug coverage through PSHB may operate as an enhanced version or supplement to Part D. Lower negotiated drug prices under Medicare now help set the base costs that PSHB plans use, which can lead to shifts in how copayments, coinsurance, and out-of-pocket limits are determined each year.

Why Are Drug Prices Changing in 2026?

Legislative background and policy updates

Recent federal laws, like the Inflation Reduction Act of 2022, have authorized Medicare to negotiate prices directly with pharmaceutical companies for select high-cost prescription drugs. This marks a significant policy update, as legal barriers previously prevented Medicare from engaging in these negotiations. The focus is on reducing overall healthcare spending, boosting price transparency, and improving affordability for retirees and those on fixed incomes.

Timeline for changes

Negotiated drug prices began rolling out for the first set of eligible drugs in 2026. The transition is gradual, with more drugs added each year. PSHB and FEHB participants saw foundational changes starting in 2025, but 2026 is a pivotal year when new negotiated prices begin having a direct effect on what you pay and how plans are structured concerning these drugs.

What Factors Impact FEHB and PSHB Plans?

Benefit design and coverage levels

Both Federal Employees Health Benefits (FEHB) and PSHB plans determine what services and medications are covered, the extent of that coverage, and the structure of cost sharing (such as copayments, coinsurance, and annual limits). The negotiated Medicare drug prices form a new benchmark for these decisions—plans update their formularies, coverage tiers, and member cost sharing each year to reflect these federal standards.

Provider access considerations

Your access to pharmacies and prescribing providers is also shaped by these changes. Plans may adjust their pharmacy networks, preferred medication lists, and rules for prior authorization to reflect the new negotiated prices and ensure compliance with Medicare requirements. Aim to review your plan’s provider directory annually to see if your preferred pharmacy or doctor remains in-network under the updated structure.

Prescription copayment and coinsurance

The share you pay for each prescription—whether as a fixed copayment or a percentage (coinsurance)—may change in both FEHB and PSHB depending on how a drug is classified under the new structure. Drugs with Medicare-negotiated prices often see reduced out-of-pocket costs, but specifics will depend on your plan’s yearly updates, the medication itself, and how it’s categorized on the plan’s formulary.

Will You Pay Less for Prescriptions?

Situations where costs might change

You may see your out-of-pocket expenses decrease for medications on Medicare’s list of negotiated drugs, especially if those were previously high-cost items. For common chronic condition medications (like those for diabetes or heart disease), negotiated pricing could reduce the amount you owe at the pharmacy counter. However, changes are tied to the annual updates from your specific PSHB or FEHB plan, as not all drugs or situations are affected equally.

What remains uncertain in 2026

Not every prescription will be directly impacted by the new negotiations. Some drugs will only become eligible in future years, and exact plan details can vary. Additionally, formularies and in-network pharmacies may shift. It is important to regularly check your plan materials and official updates from the Office of Personnel Management (OPM) for specifics about new costs, covered medications, and any changes to your network.

How Do Drug Price Changes Affect Retirees?

Impact on out-of-pocket costs

For many Medicare-eligible retirees, out-of-pocket costs could decrease for commonly used prescription medications targeted by CMS. Reductions may be more significant for individuals with extensive or chronic prescription needs. However, for drugs not included on the negotiated list, pricing will continue to follow existing plan structures, which may see more incremental changes.

Managing your prescription needs

Being proactive is key. Review your annual plan documents, notice of changes, and any updates to drug formularies. Bring a current list of prescriptions to discussions with your healthcare provider or benefits advisor to see if any of your medications are affected. Open enrollment remains a pivotal time to double-check that your plan’s network and coverage align with your personal prescription requirements.